Effectiveness of plasma exchange (biological) in liver disease
Not Applicable
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2019/07/020248
- Lead Sponsor
- Institute of Liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Grade IV DILI With T.B > 15
2) DILI Manifesting as ACLF (Acute on chronic Liver failure) /ALF (Acute Liver Failure) with no transplant option
Exclusion Criteria
1) Evidence of active infection
2) Refusal of consent or assent
3) Patients with clinical suspicion of irreversible brain injury
4) Pregnancy
5) HCC (Hepatocellular Carcinoma) or any other malignancy
6) Kidney failure
7) Portal vein thrombosis
8) Upper GastroIntestinal bleed
9) Transplant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Transplant free survival in both groupTimepoint: Day 28
- Secondary Outcome Measures
Name Time Method Development of organ dysfunction or failure in both groupTimepoint: Day 7,15 and 28